Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia.

Racil Z, Klamova H, Voglova J, Faber E, Razga F, Zackova D, Buresova L, Cetkovsky P, Mayer J

Open source

DOI
10.1002/ajh.21689
Published
2010 May
Container
American journal of hematology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ajh.21689,
  title = {Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia.},
  author = {Racil Z and Klamova H and Voglova J and Faber E and Razga F and Zackova D and Buresova L and Cetkovsky P and Mayer J},
  year = {2010},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.21689},
  url = {https://doi.org/10.1002/ajh.21689}
}

RIS

TY  - JOUR
TI  - Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia.
AU  - Racil Z
AU  - Klamova H
AU  - Voglova J
AU  - Faber E
AU  - Razga F
AU  - Zackova D
AU  - Buresova L
AU  - Cetkovsky P
AU  - Mayer J
PY  - 2010
JO  - American journal of hematology
DO  - 10.1002/ajh.21689
UR  - https://doi.org/10.1002/ajh.21689
ER  - 

APA

Z, R., H, K., J, V., E, F., F, R., D, Z., L, B., P, C., & J, M. (2010). Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia.. American journal of hematology. https://doi.org/10.1002/ajh.21689

Source records